Van Andel Institute researchers discovered that cancer risk may be determined before birth due to distinct epigenetic states ...

The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...